» Articles » PMID: 36420173

Respiratory Questionnaire-based Analysis of Awareness of COPD in a Large Multicenter Rural Population-based Study in India

Overview
Publisher Wiley
Date 2022 Nov 24
PMID 36420173
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Chronic obstructive pulmonary disease (COPD) is a more prevalent chronic lung disease with a significant health burden, and the majority of these cases receive inadequate treatment.

Methods: Prospective, observational, interview (questionnaire) based complete workup COPD study, screened 12,000 cases with chronic respiratory symptoms with cough, sputum production, and shortness of breath. A total of 6000 COPD cases were enrolled after the spirometry test. COPD cases were assessed as disease knowledge and methods of treatment offered by applying questionnaires to patients and treating physicians.

Results: In the present study, 3% of study cases were aware of their COPD illness, 54% were not having knowledge about the disease, and 43% cases were not accepting the COPD diagnosis ( < 0.0001). A total of 58% of cases received inhalation treatment as levosalbutamol monotherapy in 31% cases, levosalbutamol plus beclometasone in 18% cases, and formoterol plus budesonide or salmeterol plus fluticasone only in 9% of COPD cases ( < 0.0001). Total 42% cases received oral treatment as theophylline in 16% cases, salbutamol in 7% cases, oral steroids in 19% cases ( < 0.0001).

Conclusion: "Doctor-patient-drug trio" discordance clubbed as "difficult doctor, difficult patient, and difficult treatment" is a very crucial issue observed during diagnosis and management of COPD in peripheral settings in India.

Citing Articles

A nationwide survey of public COPD knowledge and awareness in Saudi Arabia: A population-based survey of 15,000 adults.

Alqahtani J, Aldhahir A, Siraj R, Alqarni A, AlDraiwiesh I, AlAnazi A PLoS One. 2023; 18(7):e0287565.

PMID: 37406018 PMC: 10321629. DOI: 10.1371/journal.pone.0287565.


Respiratory questionnaire-based analysis of awareness of COPD in a large multicenter rural population-based study in India.

Patil S, Patil R, Bhise M, Jadhav A Chronic Dis Transl Med. 2022; 8(4):322-330.

PMID: 36420173 PMC: 9676131. DOI: 10.1002/cdt3.47.

References
1.
Gupta D, Agarwal R, Aggarwal A, Maturu V, Dhooria S, Prasad K . Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations. Lung India. 2013; 30(3):228-67. PMC: 3775210. DOI: 10.4103/0970-2113.116248. View

2.
Yildiz F, Karakoc G, Ersu Hamutcu R, Yardim N, Ekinci B, Yorgancioglu A . [The evaluation of asthma and COPD awareness in Turkey (GARD Turkey Project-National Control Program of Chronic Airway Diseases)]. Tuberk Toraks. 2013; 61(3):175-82. DOI: 10.5578/tt.6207. View

3.
Molken M, Oostenbrink J, Miravitlles M, Monz B . Modelling the 5-year cost effectiveness of tiotropium, salmeterol and ipratropium for the treatment of chronic obstructive pulmonary disease in Spain. Eur J Health Econ. 2007; 8(2):123-35. PMC: 1913175. DOI: 10.1007/s10198-007-0039-4. View

4.
Bayram M, Akgun M . If You Know the Enemy and Your Weapons, You Need not Fear the Management of Chronic Obstructive Pulmonary Disease. Turk Thorac J. 2018; 18(4):100. PMC: 5783067. DOI: 10.5152/TurkThoracJ.2017.190917. View

5.
Grouse L, Nonikov D . The global battle to improve patients' health outcomes: COPD awareness, activities, and progress. J Thorac Dis. 2014; 6(2):161-8. PMC: 3944191. DOI: 10.3978/j.issn.2072-1439.2013.12.46. View